Rights issue in IRRAS AB (SE) — SEK 215 million

Carnegie acted as sole global co-ordinator in the SEK 215 million rights issue in IRRAS. IRRAS is a global medtech company focused on commercializing and delivering innovative medical technologies to its customers and their patients.
August 2022.